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Aim: To compare DVHs for OARs in two different positions – prone and supine – for prostate
cancer patients irradiated with a Tomotherapy unit.
Background: In the era of dose escalation, the choice of optimal patient immobilization plays
an essential role in radiotherapy of prostate cancer.
Materials and methods: The study included 24 patients who were allocated to 3 risk groups
based on D’Amico criteria; 12 patients represented a low or intermediate and 12 a high risk
group.
For each patient two treatment plans were performed: one in the supine and one in the
prone position. PTV included the prostate, seminal vesicles and lymph nodes for the high
risk group and the prostate and seminal vesicles for the intermediate or low risk groups.
DVHs for the two positions were compared according to parameters: Dmean, D70, D50 and
D20 for the bladder and rectum and Dmean, D10 for the intestine. The position accuracy
was veriﬁed using daily MVCT.
Results: Prone position was associated with lower doses in OARs, especially in the rectum.
Despite the fact that in the entire group the differences between tested parameters were not
large, the Dmean and D10 for the intestine were statistically signiﬁcant. In the case of irra-
diation only to the prostate and seminal vesicles, the prone position allowed for substantial
reduction of all tested DVH parameters in the bladder and rectum, except D20 for blad-
der. Moreover, the Dmean and D50 parameter differences for the bladder were statistically
signiﬁcant.
No signiﬁcant differences between positions reproducibility were demonstrated.
Conclusion: In patients irradiated to prostate and seminal vesicles, the prone position maysupport sparing of the rectum and bladder.
The reproducibility of position arrangement in both positions is comparable.
© 2011 Greater Poland Cancer Centre, Poland. Published by Elsevier Urban & Partner Sp.
z.o.o. All rights reserved.
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Table 1 – The single factor risk group models described
by D’Amico et al.14
Risk group Risk factor
Low risk
PSA≤10
Gleason 2–6
T1–T2a
Intermediate risk
Presence of 1 or more
PSA 11–20
Gleason 7
T2b–T2c
Presence of 1 or more66 reports of practical oncology a
1. Background
Radiotherapy is one of the main radical treatment methods
for patients with locally advanced prostate cancer, contribut-
ing to the prolongation of overall survival (OS) anddisease-free
survival (DFS). In case of early stage prostate cancer, irradia-
tion is an alternative treatment method to surgery and the
outcome following both treatments are similar.1–3 Such a high
therapeutic efﬁciency is achievable through dose escalation,
which would not be possible without strong development of
irradiation techniques.4 It has been shown in a number of ran-
domized trials that doses above 66Gy contribute to a longer
duration of DFS and biochemical control.5–8 Through intensity
modulated radiation therapy (IMRT), it has became possible
to provide a relatively safe treatment with doses to prostate
above 70Gy and comparable doses for adjacent organs at risk
(OAR) (bladder and rectum) as for 3D technique.9 In recent
years, the high conformal techniques like Tomotherapy or
CyberKnife has become available. With these techniques, it
is possible to obtain a larger dose-decrease gradient outside
the target, so dose escalation has become even safer.10
Simultaneously with the introduction of new techniques,
attempts are also being made to reduce the doses in the
organs at risk through appropriate patient preparation for
each fraction of treatment. The use of rectal balloon and
bladder ﬁlling reduces unexpected changes in volume of the
rectum or bladder and decreases prostate motion.11,12 Search-
ing for newways to escalate thedose. immobilizationmethods
were brought to focus. In the literature there are various
papers exploring differences in dose distribution relative to
a treatment position – supine or prone.13–17 However, previ-
ously published works focused on the 3D planning technique.
Techniques currently used, such as IMRT or Tomotherapy, are
much more conformal, thus the planning dose distribution
between both positions can be more signiﬁcant.
2. Aim
The aim of this study is to compare two different stabilisa-
tion techniques of patients irradiated for localised or locally
advanced prostate cancer. For this purpose a comparison of
dose volume histograms (DVHs) in the supine and prone treat-
ment positions will be carried out. Through daily megavoltage
computed tomography (MVCT) positioning accuracy in the
supine and prone position will also be evaluated.
3. Materials and methods
The study included 24 patients with locally advanced prostate
cancer radically treated with Tomotherapy at the Radio-
therapy Department II at the Greater Poland Cancer Centre
between July 2009 and May 2010. No exclusion criteria
were applied during recruitment to this study. Patients were
between 55 and 86 years of age (average 65.90, median 64.00,
standard deviation (SD) 7.53), with body weight from 65 to
105kg (average 84.18, median 83.00, SD 11.90) and height in
the range of 159 to 180 cm (average 170, median 170, SD 0.06).
For all patients, the body mass index (BMI) was calculated andHigh risk
PSA>20
Gleason 8–10
≥T3
its value ranged from 22.10 to 33.30 (average 28.40, median
28.90, SD 3.30).
Histopatology examination revealed a low degree of malig-
nancy (G1) in 2 patients, intermediate degree (G2) in 8 and high
degree (G3) in 10 patients. In 4 cases, the degree of biologi-
cal malignancy was determined. The Gleason score in biopsy
material varied in this group of patients from 6 to 9 (median 6,
SD1.35). The level of prostatic speciﬁc antigen (PSA) at the time
of diagnosis ranged from 4.20 to 96.54ng/ml (average 20.82,
median 11.90, SD 22.47). Based on the transrectal ultrasound
(staging), Gleason score and initial PSA (iPSA) value, patients
were allocated to one of the three risk groups according to
the criteria described by D’Amico (Table 1).18 There were 12
patients in the high risk group, 7 in the intermediate and 5 in
the low risk group.
For each patient, two different immobilization methods –
supine and prone – were used for radiotherapy planning. In
the ﬁrst case patient’s legs and pelvis were stabilized with the
knee-ﬁx stand (Sinmed Combiﬁx SYS/2P), the patient hold-
ing his hands clasped on the chest. For the prone position,
a belly-board stand (Sinmed Bellyboard BB-CF/2P) was used.
Computed tomography (CT) was performed in both positions
for each patient at an interval of not more than 5min. 30min
before this examination patients were asked to empty their
bladder and then to drink 500ml of water. No pharmacological
or mechanical preparations like Enema or endorectal balloon
were used.
In all cases, patient radiotherapy was planned with Hi-
Art Tomotherapy Treatment Planning System. The delineated
clinical target volumes (CTVs) were differentiated according
to D’Amico risk groups. For patients in the low and intermedi-
ate risk groups, CTV included the prostate gland with seminal
vesicles. For patients in the high risk group, the CTV included
the prostate gland, seminal vesicles and external iliac, inter-
nal iliac, presacral and distal common iliac lymph nodes. The
margins for planning target volume (PTV) ranged from 10mm
around designed CTV to 7mm from the rectum side. The fol-
lowing OARs were also determined in all patients: the bladder,
the rectum, bowels, left and right femoral heads. The rectum
was delineated from the level of anal sphincter muscle to the
sigmoid colon and the bladder from its apex to the bottom.
Both OARs were determined as the whole volume of organs,
not only the rectum or bladder wall. The contours of the bow-
els covered the entire peritoneal cavity below the upper edge
of the 5th lumbar vertebra. Target volumes and OARs were
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Table 2 – Dose volume histograms comparison of organ at risk for entire group.
Organ at risk DVH parameter % of prescribed dose
in supine position
% of prescribed dose
in prone position
p value
Bladder
Dmean 56.05 54.93 0.366
D70 32.85 31.18 0.241
D50 50.41 47.74 0.156
D20 87.01 86.60 0.076
Rectum
Dmean 56.38 55.62 0.607
D70 33.89 34.55 0.724
D50 52.69 50.18 0.380
D20 90.27 86.90 0.303
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etermined for each patient and in the supine as prone posi-
ions.
Radiotherapy was planned in a helical technique (helical
omotherapy) using modulated photon beam of 6MV. For each
osition, the planned dose distribution and optimization of
he treatment plan were calculated based on the aforemen-
ioned Hi – Art Tomotherapy Planning System. During the plan
reparation, the doses for OARs were reduced to a minimum
maintaining the dose homogeneity in PTV between 95 and
07%, according to the protocol ICRU 50 and 62.19,20
Patients were irradiated according to the treatment plan
hat was selected by comparison of the planned dose distri-
ution inOARs in both immobilizationmethods. The following
VHs parameters were compared: Dmean (average dose in
hole volume of OAR), D70 (dose given to 70% of OAR volume),
50 (dose given to 50% of OAR volume) and D20 (dose given to
0% of OAR volume). The accuracy of the treatment was ver-
ﬁed by daily MVCT on the Tomotherapy unit. The resulting
mages were compared with the reference Images – CT slices
erformed for treatment planning.
For the sake of statistical analysis, the tested group was
ivided into two subgroups according to structures present
n the target volume. The ﬁrst subgroup consisted of patients
olely irradiated for the prostate and the seminal vesicles,
hile the second group consisted of patients in whom the tar-
et volume included the prostate, the seminal vesicles and the
elvic lymph nodes.
The material was statistically analyzed using StatSoft Sta-
istica v.8 software. The relationships between parameters
Table 3 – Dose volume histograms comparison of organs at risk
vesicles.
Organ at risk DVH parameter % of prescrib
in supine po
Bladder
Dmean 48.16
D70 25.47
D50 41.94
D20 76.73
Rectum
Dmean 48.67
D70 23.80
D50 40.44
D20 87.17
D5 100.80
Intestine
Dmean 2.86
D10 7.53100.46 0.030
14.28 0.009
33.93 0.007
Dmean, D70, D50 and D20 for the bladder and rectum were
tested using t-Student Test or Wilcoxon Test for dependent
variables.
4. Results
The analysis of DVHs for the entire group of patients is pre-
sented in Table 2. The value of DVH parameters is expressed
as a percentage of total prescribed dose. The average values
of Dmean, D70, D50 and D20 for the bladder were lower in the
prone position and the differences between these parameters
in both treatment positions amounted 1.12%, 1.67%, 2.67% and
0.41%, respectively. There were no statistically signiﬁcant dif-
ferences observed between these parameters (t-Student Test,
Wilcoxon Test). The analysis of DVHs for the rectum showed
that the differences between the supine and prone position
were not signiﬁcant. Only the D5 difference for the rectum
was statistically signiﬁcant (p=0.03) in favor of stabilisation
on belly-board, but its value amounted to 0.52% of prescribed
dose. More signiﬁcant differences were observed for the bow-
els. The average Dmean and D10 parameters were lower by
3.3% and 5.81%, respectively, in the prone position (p=0.009
and p=0.007).
A comparisonof dose volumehistogramparameters for the
subgroup irradiated to the prostate gland and seminal vesi-
cles showed more signiﬁcant differences. The whole analysis
is presented in Table 3. The detailed analysis of DVHs for the
bladder demonstrated the superiority of the prone position
for subgroup irradiated on prostate gland and seminal
ed dose
sition
% of prescribed dose
in prone position
p value
44.80 0.070
21.75 0.092
36.81 0.829
77.51 0.782
44.18 0.050
21.09 0.116
31.98 0.032
79.28 0.053
99.85 0.016
2.46 0.109
5.07 0.260
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Table 4 – Dose volume histograms comparison of organs at risk for subgroup irradiated on prostate gland, seminal
vesicles and pelvic lymph nodes.
Organ at risk DVH parameter % of prescribed dose
in supine position
% of prescribed dose
in prone position
p value
Bladder
Dmean 63.94 65.05 0.497
D70 40.23 40.61 0.837
D50 58.87 58.66 0.929
D20 97.28 95.68 0.059
Rectum
Dmean 64.10 67.05 0.116
D70 43.98 48.01 0.222
D50 64.94 68.38 0.383
D20 93.37 94.52 0.637
.17
.30
.03D5 101
Intestine
Dmean 32
D10 69
– the Dmean, D70 and D50 were lower by 3.36%, 3.72% and
5.13%, respectively. Only the D20 parameter was 0.78% higher
in case of the prone stabilisation. These differences were not
statistically signiﬁcant. Comparison of rectal dose distribution
for this subgroup showed greater differences – Dmean was
an average of 4.49% lower, while the D70, D50 and D20 were
lower by 2.71%, 8.46%and 7.89%, respectively, in the case of the
prone immobilization. The Dmean and D50 differences were
statistically signiﬁcant (p=0.050 and p=0.032, respectively).
The analysis of the second subgroup is presented in Table 4.
It showed that the Dmean in the bladder and rectum were
lower by 1.11% and 2.95%, respectively, in the supine position.
However, the detailed analysis of bladder doses showed that
D70 and D50 parameter differences were lower than 0.5% of
prescribed dose while D20 was 1.6% higher in the supine posi-
tion. Comparison of D70, D50 and D20 parameters conﬁrmed
the favourable distribution of rectal doses for supine immobil-
isation – the values of parameter differenceswere 4.03%, 3.44%
and 1.15%, respectively. All of these differences were not sig-
niﬁcant, although the p value of D20 parameter for the bladder
amounted to 0.059.More signiﬁcant differenceswere observed
for the bowels. The average Dmean and D10 parameters were
lower by 5.12% and 3.65%, respectively, in the prone position.
Moreover, the Dmean differences were statistically signiﬁcant
(p=0.028).
There were 654 daily MVCT matching analyzed – 336 for
supine and 318 for prone immobilization. The average value
of shifts in the X-, Y- and Z- axes were −0.35 (SD=3.83),
−0.18 (SD=3.36) and 0.37 (SD=2.62)mm, respectively, in the
supine position and 0.44 (SD=3.54), −0.52 (SD=3.43) and 0.09
(SD=2.78)mm for stabilization on belly-board. The average
rotation value for both positions amounted to 0.7◦. There-
fore, the differences in the arrangement of reproducibility
were comparable. Taking into account the margins for PTV
(0.7–10mm) both treatment immobilization methods were
safe in terms of reproducibility of the position.
5. DiscussionIn the present study, the prone position during radiotherapy
in patients with prostate cancer was associated with lower
doses in OARs, especially in the rectum. Despite the fact that
in the entire group of patients the differences between tested101.08 0.732
27.18 0.028
65.40 0.620
parameters were not large, the Dmean and D10 for the bowels
were statistically signiﬁcant. In cases of irradiation of only the
prostate gland and the seminal vesicles, immobilization using
belly-board allowed for substantial reduction of all tested dose
volume parameters in the bladder and rectum, except for D20
for the bladder. The decrease of D50 parameter for the bladder
by 5.13% and for the rectum by 8.46% of prescribed dose trans-
lates into reduction by 4.0Gy and 6.6Gy, respectively, for 78Gy
PTV. For the subgroup of patients irradiated to the prostate,
seminal vesicles and pelvic lymph nodes, the prone position
was associated with signiﬁcant bowel sparing.
In the past decade, several studies have been published
about immobilization for radiotherapy of prostate cancer.
Most of them showed a beneﬁcial dose distribution in the
prone position. One of the ﬁrst studies comparing the supine
and prone positions was reported already in 1997. Zelefsky
et al.13 proved signiﬁcantly lower doses in the rectum for plans
of irradiation in the prone position. Patients were immobi-
lized using an aquaplast. The night before CT they were given
enema and during the test a rectal catheter was inserted.
Radiotherapy was planned using the 6-ﬁeld 3D technique. The
dose comparison was focused only on the Dmean parameter
(mean dose in the volume of rectal wall) and V95 (rectal wall
volume received 95% of prescribed dose). The authors did not
observe signiﬁcant differences for doses in the bladder, which
could be due to the planning with an empty bladder. Filling
of the bladder would increase the volume and move part of
the bladder’s volume away from the target area. Zelefsky drew
attention to the fact that even a small increase in the distance
between the prostate and the anterior rectal wall in prone
position contributes to a substantial decrease in dose for the
rectal wall.
In turn, McLaughlin et al.14 compared the effect of the
position and irradiation technique (4-ﬁeld vs. 6-ﬁeld 3D tech-
nique) on the dose distribution in OARs. The study included 10
patients in whom only the prostate or the prostate with sem-
inal vesicles was irradiated. CT was performed with an empty
bladder. Authors showed that in the whole group of patients
planned dose distribution in the front wall of the rectum was
lower in the prone position, regardless of the technique used.
However, the comparison focused on volumes that received
80% and 90% of prescribed dose. No differences in DVHs
for the bladder were shown. Like Zelefsky,13 McLaughlin14
showed that in the prone position the rectum is located fur-
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her away from the target and hence the doses are lower. The
uthors also observed that the increase in this distance is
he result of both the anterior displacement of the prostate
rom the rectum and the retraction of the rectum against the
acrum; the anatomical mechanism of this phenomenon is
nknown. Based on these results, McLaughlin suggested that
he patient’s immobilisation is more important for DVHs than
he number of ﬁelds in the 3D technique.
The above-mentioned results were conﬁrmed in a phase
I study published by O’Neil et al.15 The analysis included
atients in whom only the prostate with seminal vesicles was
rradiated. CT for treatment planning was performed with-
ut any special stabilization and rectum preparation. Patients
ere asked to maintain a ﬁlled bladder during the test and
he subsequent radiation. Despite the use of only the 3-ﬁeld
D technique, the authors obtained a statistically signiﬁcant
eduction of V70 (p<0.001) and V50 (p=0.011) parameter for
he rectum in prone position.
Different results were obtained by Baylay et al.16 in their
andomised study of 28 patients. However, different patterns
ere used to prepare patients for each treatment position –
upine with a full and prone with an empty bladder. More-
ver, the PTV covered only the prostate gland without seminal
esicles. Treatment plans were performed using the 6-ﬁeld 3D
echnique. Baylay et al. demonstrated statistically signiﬁcant
ower dose in the rectum and bladder for the supine position.
hese results were signiﬁcant only if the margins for PTV in
he prone position were larger due to the greater motion of
he gland in the sagittal axis, based on the analysis of por-
al image alignment and veriﬁcation to bones structures and
ducial markers. These observations were not conﬁrmed by
ther studies.14,17,21 In the case of the same margins for PTV
n both positions, the dose differences were not statistically
igniﬁcant.
Favorable dose distribution in the rectum for the supine
osition was also shown by Kato et al.22 But this comparison
eferred to the IMRT technique for the supine position and
he 3D technique for the prone position. They also observed
n increase in the mean distance between the rectum and
rostate by about 5mm (in some cases more than 20mm) in
he prone treatment position. The application of such a highly
onformal technique as IMRT or Tomotherapy for the prone
osition could signiﬁcantly change the presented results.
The choice of appropriate position is one of the basic and
ost important aspects of treatment planning. A number of
vailable accessories enable a faithful reproducibility on the
asis of skin markers, bone and soft-tissue structures in both
he supine and prone positions. Traditionally accepted stan-
ard for irradiation of patients with prostate cancer is the
upine position. However, there are not available clear and
eliable research data on large groups of patients conﬁrm-
ng the superiority of this position in terms of reproducibility,
isplacement of internal organs and, above all, the planned
ose distribution in organs at risk. Additionally, previously
ublished studies related to irradiation in the 3D technique
hich in the era of dose escalation has given way to more
onformal techniques such as IMRT or Tomotherapy. The pre-
ented data conﬁrm the need to carry out study on large group
f patients to determine an optimal position during prostate
ancer irradiation in the era of highly conformal radiotherapy.iotherapy 1 6 ( 2 0 1 1 ) 65–70 69
6. Conclusion
In patients irradiated to the prostate and seminal vesicles,
the prone position may support sparing of the rectum and
bladder.
The prone position on the belly-board stand is associated
with signiﬁcant bowel sparing in all patients irradiated to
prostate cancer, especially those from the high risk group.
The reproducibility of position arrangement in both treat-
ment positions is comparable on the basis of daily MVCT
veriﬁcation.
The study on a large group of patients is needed to ﬁnally
determine an optimal position during prostate cancer irradi-
ation.
Financial support
This study was supported by the Greater Poland Cancer Centre
(grant no. 1 dated 29 June 2009).
e f e r enc e s
1. D’Amico AV, Whittington R, Malkowitcz SB, Cote K, Loffredo
M, Shultz D, et al. Biochemical outcome after radical
prostatectomy or external beam radiation therapy for
patients with clinically localized prostate carcinoma in the
prostate speciﬁc antigen era. Cancer 2002;95:281–6.
2. Potters L, Klein EA, Kattan MW, Reddy CA, Ciezki JP, Reuther
AM, et al. Monotherapy for stage T1–T2 prostate cancer:
radical prostatectomy, external beam radiotherapy or
permanent seed implantation. Radiother Oncol 2004;71:29–33.
3. Kanikowski M, Skowronek J, Kubaszewska M, Chicheł A,
Milecki P. Permanent implants in treatment of prostate
cancer. Rep Pract Oncol Radiother 2008;13:160–7.
4. Maciejewski B, Petrovich Z, Lange D, Borówka A.
Radiotherapy for locally advanced prostate cancer: dogmas
and dilemmas. Rep Pract Oncol Radiother 2003;8:97–110.
5. Pollack A, Smith LG, von Eschenbach AC. External beam
radiotherapy dose response characteristics of 1127 men with
prostate cancer treated in the PSA era. Int J Radiat Oncol Biol
Phys 2000;48:507–12.
6. Valicenti R, Lu J, Pilepich M, Asbell S, Grignon D. Survival
advantage from higher-dose radiation therapy for clinical
localized prostate cancer treated on the radiation therapy
oncology group trials. J Clin Oncol 2000;18:2740–6.
7. Levitt SH, Khan FM. The rush to judgement: does the
evidence support the enthusiasm open three-dimensional
conformal radiation therapy and dose escalation in the
treatment of prostate cancer? Int J Radiat Oncol Biol Phys
2001;51:871–9.
8. Zelefsky MJ, Leibel SA, Gaudin PB, Kutcher GJ, Fleshner NE,
Venkatramen ES, et al. Dose escalation with
three-dimensional conformal radiation therapy affects the
outcome in prostate cancer. Int J Radiat Oncol Biol Phys
1998;41:491–500.
9. Bindhu J, Supe S, Pawar Y. Intensity modulated radiotherapy
(IMRT) the white, black and gray: a clinical perspective. Rep
Pract Oncol Radiother 2009;14:95–103.
10. Ceylan C, Kucuk N, Ayata HB, Guden M, Engin K. Dosimetric
and physical comparison of IMRT and CyberKnife plans in
the treatment of localized prostate cancer. Rep Pract Oncol
Radiother 2010;15:181–9.
nd ra
22. Kato T, Obata Y, Kadoya N, Fuwa N. A comparison of prone70 reports of practical oncology a
11. Court LE, D’Amico AV, Kadam D, Cormack R. Motion and
shape change when using an endorectal balloon during
prostate radiation therapy. Radiother Oncol 2006;93:131–6.
12. Smeenk RJ, Teh BS, Butler EB, van Lin EN, Kaanders JH. Is
there a role for endorectal balloons in prostate radiotherapy?
A systematic review. Radiother Oncol 2010;95:277–82.
13. Zelefsky MJ, Happersett L, Leibel SA, Burman CM, Schwartz
L, Dicker AP, et al. The effect of treatment positioning on
normal tissue dose in patients with prostate cancer treated
with three-dimensional conformal radiotherapy. Int J Radiat
Oncol Biol Phys 1997;37(1):13–9.
14. McLaughlin PW, Wygoda A, Sahijdak W, Sandler HM, Marsh
L, Roberson P, et al. The effect of patient position and
treatment technique in conformal treatment of prostate
cancer. Int J Radiat Oncol Biol Phys 1999;45(2):407–13.
15. O’Neil L, Armstrong J, Buckney S, Assiri M, Cannon M,
Holmberg O. A phase II trial for the optimisation of
treatment position in the radiation therapy of prostate
cancer. Radiother Oncol 2008;88:61–6.
16. Baylay AJ, Catton CN, Haycocks T, Kelly V, Alasti H, Bristow
R, et al. A randomized trial of supine vs. prone positioning in
patients undergoing escalated dose conformal radiotherapy
for prostate cancer. Radiother Oncol 2003;70:37–44.diotherapy 1 6 ( 2 0 1 1 ) 65–70
17. Widler RB, Chittenden L, Mesa A, Bunyapanasarn J, Agustin
J, Lizarde J, et al. A prospective study of intrafraction
prostate motion in the prone vs. supine position. Int J Radiat
Oncol Biol Phys 2010;77(1):165–70.
18. D’Amico AV, Whittington R, Malkowicz SB, Weinstein M,
Tomaszewski JE, Schultz D, et al. Predicting prostate speciﬁc
antigen outcome preoperatively in the prostate speciﬁc
antigen era. J Urol 2001;166(6):2185–8.
19. ICRU Report 50. Prescribing, recording and reporting photon
beam therapy. Maryland: Bethesda; 1993.
20. ICRU Report 62. Prescribing, recording and reporting photon
beam therapy (Supplement to ICRU Report 50). Maryland:
Bethesda; 1999.
21. Bittner N, Butler WM, Reed JL, Murray BC, Kurko BS, Wallner
KE, et al. Electromagnetic tracking of intrafraction prostate
displacement in patients externally immobilized in the
prone position. Int J Radiat Oncol Biol Phys 2010;77(2):490–5.three-dimensional conformal radiotherapy with supine
intensity-modulated radiotherapy for prostate cancer:
which technique is more effective for rectal sparing? Br J
Radiol 2009;82:654–61.
